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Burn injury is a significant form of trauma that leads to alterations in the functionality of 
multiple body systems. One vital system that promotes both healing and protection from invasive 
pathogens is the immune system. After burn injury the immune system is severely impeded. 
However, models of burn injury are unable to successfully recapitulate phenotypes seen among 
burn-injured patient populations. Studies indicate that presence of burn-associated comorbidities 
can greatly improve the translatability of models and that study of comorbidities is essential for 
improving treatment of patients. 
Here we report the development of a model of repeated bacterial exposure after burn 
injury. This model is able to recapitulate immune cell recruitment and alterations in cytokine 
production that mimic those seen among patient populations. Namely, we found that repeated 
infections lead to increased bacterial burden after burn injury, and the loss of a lab-derived burn 
“protection” phenotype that is common in the literature late after burn injury. We found that this 
phenotype corresponds with burn-dependent alterations in pulmonary innate immune cell 
numbers and function. We believe that these cells represent a potential target for therapeutic 
intervention. 
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Additionally, we have worked to establish a model of inhalation injury to examine 
inhalation-dependent alterations in the immune profile that take place both independently and 
concomitant with burn injury. We have found that inhalation and burn injury independently 
contribute to damage in our murine model of inhalation. We examined the pulmonary 
compartment and found that burn and inhalation independently affect the recruitment of 
neutrophils to either the airspace or the lung tissue. We also found that inhibition of nitric oxide 
production can ameliorate damage that takes place after inhalation injury, representing a 
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CHAPTER 1: INTRODUCTION 
 
Each year approximately 486,000 individuals experience a burn injury requiring medical 
treatment [1]. These patients have an extended hospital stay relative to other forms of trauma, 
resulting in a treatment that is not only difficult and lengthy, but costly [2]. The average 
treatment cost per burn patient can exceed $88,000 USD [3]. One leading cause of lengthened 
hospital stay after burn injury is the presence of a burn-associated comorbidity. Patients who 
present with comorbidities of burn injury often require additional therapeutic intervention and 
experience complicated clinical outcomes relative to other patients [4].  
When a patient experiences a significant burn injury, the wound tissue releases damage-
associated molecular patterns (DAMPS) that can alter many systems throughout the body [5]. 
One major compartment affected by DAMPS is the immune system. Burn injury is known to 
lead to significant systemic immune dysregulation [5-8]. DAMPS released into the body lead to 
an overall systemic inflammatory response syndrome (SIRS), in which the immune system 
becomes activated in response to damage [9, 10]. Immune dysregulation and activation after 
burn injury is often typified by the presence of altered levels of cytokines, chemokines, and 
immune cells [11].  
In the case of significant trauma such as burn injury, damaged tissue causes the release of 
a cytokine storm, which not only activates the SIRS response, but also triggers an overall 
compensatory anti-inflammatory immune response (CARS) [12]. Historically the SIRS and 
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CARS responses were thought to be biphasic in nature, with a SIRS phenotype arising early after 
injury and a CARS response characterizing the late response to injury [13].  However, recent 
developments in the field indicate that typical injury results in the simultaneous initiation of both 
the SIRS and CARS response, with a different phenotype overriding the overall response at any 
given time. The ability to detect simultaneous presence of both pro- and anti-inflammatory 
mediators of immunity has been designated a mixed antagonist response syndrome (MARS) [14-
21]. Although the MARS phenotype more fully encompasses the immune responses that take 
place after injury, it is possible to detect overriding immune responses characterized as being 
largely SIRS or CARS at any given timepoint after injury. However, it is important to emphasize 
the complexity of the immune response during the treatment and recovery of patients due to the 
presence of both pro-and anti-inflammatory signals. 
As previously mentioned, immediately after burn injury there is an overwhelming shock 
response that is characterized by the presence of DAMPS, cytokine storm, and abnormal immune 
cell profiles which are characteristic of SIRS. In order to study this early response and improve 
interventions available for burn patients many researchers have generated animal models that 
characterize the SIRS response early after burn injury [10, 22-26]. However, very few studies are 
able to generate an animal model that recapitulates the CARS phenotype seen among the human 
population. In fact, many researchers have actually generated data indicating that late after 
injury, burned animals are more capable of mounting a pro-inflammatory response and clear a 
bacterial infection than their sham counterparts [27-33]. This phenomenon can be ablated 
through elimination of various immune cell compartments [27, 29], however, this phenomenon 
represents a significant flaw in the application and use of animal models for the study of the 
immune response after significant trauma. It is essential that scientists utilize animal models that 
3 
are successfully recapitulate phenotypes seen among the patient population, and to that end 
modifications of models currently utilized are necessary. 
There are major markers that have been identified as being key and typical of patient 
responses after injury. Specifically, we have previously demonstrated that aberrant production of 
IL-10 from several cell types, including macrophages and neutrophils, are likely a major factor 
contributing to the immunopathology responsible for susceptibility to infection [16, 22, 34, 35], 
whereby our group has indicated the prognostic potential of IL-10/IL-12 protein ratios within 
bronchial washes on predicting lung and systemic infections following severe burn trauma 
(Figure 1.1, [16, 17, 22]). Recent gene expression analysis of peripheral blood mononuclear cells 
(PBMCs) from burn patients has shown a strong correlation between increased IL-10, increased 
arginase 1 (ARG1), reduced IL-12 and reduced nitric oxide synthase 2 (NOS2) expression with 
burn severity and susceptibility to bacterial infection. As burn injury generates numerous 
inflammatory stimuli including DAMPs that activate innate immune cells [17, 36], 
inducing/regulating pro- and anti-inflammatory responses, our group has also defined a profile of 




When patients present at the hospital with a burn injury, their treatment is often 
complicated due to the presence of a burn-associated comorbidity. Multiple studies have shown 
that the presence of a burn-associated comorbidity further alters the innate and adaptive immune 
responses to burn injury [37-43]. Additionally, research indicates that inclusion of comorbidities 
associated with burn injury eliminates the burn-mediated “protective” response late after injury 
and more closely recapitulates phenotypes seen among the human population [37, 38, 44]. 
Research focused on human patients ensures the translational relevance of any results found and 
is important for understanding the variables that lead to disease progression. However, animal 
models are essential for understanding the underlying cellular and molecular mechanisms of 
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immune-mediated disease progression. Animal models permit the study of systems that are 
inaccessible in human patients and also allow for testing of various potential therapeutic targets 
to improve overall outcomes of disease and/or injury. Therefore, improved models, such as those 
that include comorbidities of burn injury are necessary in order to improve understanding of 
burn-mediated immunopathology.  
 
Burn and Inhalation injury 
 Approximately 10-20% of all burn patients present to the hospital with a burn-associated 
inhalation injury [45]. Presence of an inhalation injury can cause a 20% increase in mortality 
among burn patients, significantly lengthen hospital stay, and result in increased incidence of 
bacterial infection [46-48]. In fact, inhalation injury is a leading cause of burn-associated 
mortality [49, 50]. Many models of inhalation injury have been generated, however few 
improvements in treatment of patients with inhalation injury have been achieved [45]. 
Additionally, while multiple studies have examined the immune-mediated effects of inhalation 
injury [51-53], few have examined the combined effects of burn and inhalation injury in spite of 
the fact that combined injury results in damage more severe than can be attributed to each injury 
alone [39]. 
 Studies have indicated that presence of severe inhalation injury leads to increased levels 
of multiple immune-related cytokines in collected bronchoalveolar lavage fluid (BAL), 
specifically increased levels of interleukin-8 (IL-8), IL-4, IL-6, IL-9, IL-15, interferon-, 
granulocyte-macrophage colony-stimulating factor (GM-CSF) and monocyte chemotactic 
protein-1 (MCP-1) [54]. Additionally, multiple studies have demonstrated that presence of 
inhalation injury is strongly associated with increased numbers of neutrophils collected from 
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BAL [54-58]. Presence of neutrophils in BAL after inhalation injury has additionally been 
associated with overall immune dysfunction and susceptibility to bacterial infection [59-61]. 
Neutrophil presence has additionally been associated with protein deposition in the airway, and 
associated pulmonary damage [60, 62, 63].  
Neutrophils present in the lungs after inhalation injury release proteases, oxidants, and 
their downstream products such as nitrate and nitrite, which can lead to significant damage to the 
lungs [64, 65]. Multiple studies have detected indicators of oxidative stress in the pulmonary 
compartment after inhalation injury [45, 66, 67],  and that inhibition of molecules involved in 
production of oxidants such as nitric oxide synthase (NOS) can lead to improved outcome after 
inhalation injury [68, 69]. Indeed, inhibition of inducible NOS (iNOS) has been proposed and 
tested as a potential therapeutic treatment of inhalation injury in ovine models [70, 71]. It has 
been reported that multiple studies are currently examining the therapeutic potential of inhibition 
of NOS, modulators of reactive nitrogen species, and antioxidants in treatment of inhalation 
injury [72]. These studies are important in order to be able to generate potential improvements in 
treatment of inhalation injury. 

Burn and infection 
Patients who are admitted to the hospital generally experience a shift in their overall 
microbiota and develop a profile similar to that of both the nurses who treat them as well as the 
hospital environment [73, 74]. Due to the nature of burn injury, burn patients experience barrier 
dysfunction resulting in wounds that commonly become infected [75]. Burn wounds also lead to 
significant immunosuppression in patients that can allow infections to develop into sepsis, 
central line infections, and pneumonia [8, 11, 76-79].  In fact, the leading cause of mortality 
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among burn patients is the presence of a bacterial pneumonia [80], and studies have indicated 
that repeated infectious episodes significantly increase mortality among patients [81]. In order to 
decrease infection-associated mortality among burn patients it is essential that further studies be 
conducted.  
Many studies have been conducted using mouse models to examine burn-dependent 
changes in the immune system and how these changes alter the response to bacterial infection 
[22, 82-84]. Animal models have been successful at recapitulating immunosuppression and 
susceptibility to bacterial infection early after burn injury [85-91]. Various labs have sought to 
identify potential vaccines and treatments that could generate bacterial-specific immune 
responses to improve outcomes in the face of infection. Multiple groups have applied bacterial 
byproducts such as flagellin or PilA from Pseudomonas aeruginosa to generate vaccines to 
decrease bacterial burden and associated mortality after burn injury [92-94]. Additional groups 
have focused instead on altering host responses in order to promote a response that will result in 
increased clearance of bacterial presence and improve outcomes. Burn injury leads to 
significantly altered metabolism among patients [76, 86], which is known to alter the immune 
profile [95, 96]. In order to improve the overall immune response some labs have targeted host 
metabolic responses through insulin therapy to decrease overall systemic inflammation and 
promote bacterial clearance [97, 98]. Other labs have chosen to more directly target the immune 
response by administering granulocyte colony-stimulating factor (G-CSF) to improve survival 
after injury and promote clearance of bacteria [29]. 
Although murine models of burn injury are able to recapitulate immunosuppression early 
after burn injury, many labs have found that late after burn injury mice are protected from 
bacterial infection and have improved clearance relative to their sham counterparts [27, 28, 30, 
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31, 33]. Some labs postulate that this protection is largely due to the recruitment of neutrophils to 
the pulmonary vasculature after burn injury [27, 28], and have demonstrated that elimination of 
the neutrophil population using an antibody against Ly6G results in loss of this protective 
phenotype. Additional studies have indicated that the presence of burn and an additional 
comorbidity of burn injury results in the loss of the burn-associated protective phenotype as well 
[37, 38, 99]. 
 
Burn and alcohol 
Ingestion of alcohol is known to impair judgement and is often associated with 
experiencing a trauma [100]. Therefore, patients who present to the burn center have a high 
probability of being intoxicated. Studies have indicated that intoxicated patients who present to 
the hospital with a burn injury have significantly increased mortality, frequent intubations, 
delayed healing, increased infectious complications and lengthy hospital stays relative to non-
intoxicated patients [101-107]. Burn injury is known to alter metabolism of patients, an effect 
that is further exacerbated with alcohol consumption [108].  
Analysis of the patient population indicates that intoxicated patients who present with 
burn injury span both chronic alcohol abusers and acute binge drinkers [109-112]. This indicates 
that animal models of both chronic and acute alcohol exposure are necessary to accurately reflect 
clinical outcomes. Animal studies have demonstrated that intoxication at the time of burn injury 
additionally leads to significant immune dysfunction within the splenic [113], intestinal [102, 
114-116], adipose [117, 118], skeletal [108], pulmonary [119-121], vascular [122] and 
hypothalamic-pituitary-adrenal compartments [123]. Due to the systemic effects of alcohol 
intoxication it is thought that immune consequences of intoxication during burn injury are 
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systemic as well and lead to loss of protection and an inability to fight bacterial infectious agents. 
Alcohol exposure is known to alter levels of reactive oxygen and nitrogen species, glutathione 
metabolism, bone formation and wound healing [108], each of which is known to be involved in 
regulation of immune cell activity [124-127]. It is therefore not surprising that intoxication leads 
to alteration of the immune compartment through cellular mechanisms involving each of these 
pathways. Some groups postulate that modulation of these pathways through use of compounds 
such as glutathione precursor supplementation may improve negative consequences of burn 
injury during intoxication [108]. The immune compartment is a potentially powerful therapeutic 
target to promote improved healing and decreased mortality after burn injury while intoxicated 
[128].  
 
 Burn and ageing 
Recent studies indicate that burn injury of the aged population is associated with 
worsened physical conditioning and quality of life after injury, and increased mortality [129-
131]. Treatment strategies for older patients who have experienced a burn injury have not led to 
significant changes in length of hospitalization or mortality [132].  
 It has long been noted that elderly patients experience altered immune responses relative 
to young patients due to immunosenescence [133], a condition further complicated by the 
presence of a burn injury [134]. Elderly patients commonly have elevated levels of inflammatory 
cytokines, and upon experiencing a burn injury, aged patients will generate a stronger pro-
inflammatory cytokine response than their younger adult-aged counterparts [134].  
 Animal studies comparing immune responses in mice of differing ages indicated that 
murine models are able to recapitulate age-dependent differences in cytokine responses to burn 
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injury [135-137]. These differences are related to alterations in immune cell phenotype and 
function and play an important role in cellular polarization in response to burn injury [138]. Age-
dependent alterations in cytokine responses are associated with delays in wound healing, and 
imply that studies should examine therapies focused on decreasing the expression of these 
cytokines in order to promote healing [139, 140]. Multiple groups have found that in aged mice, 
alterations in the cytokine response to burn injury may lead to deficiency in some, but not all 
immune cell migration to the wound site, potentially altering progression of wound healing and 
preventing a typical healing response [141, 142], a response that leads to increased susceptibility 
to bacterial infection in aged mice [143]. Additional studies have indicated an important role of 
multiple molecular immune markers in promoting a healing response after burn injury, such as 
hypoxia inducible factor-1 (HIF-1) which mediates migration of immune cells from the bone 
marrow to the site of injury to promote the healing response [142]. It is possible that immune 
mediators such as HIF-1 would be viable targets of immunotherapeutic treatment after burn 
injury. Additional studies indicate that cytokine therapy may potentially be successful in the 
treatment of elderly burn patients [144], however it is important to note that in an aged 
population cells do not respond as robustly to cytokines present [143].  
 
Discussion 
 Patients who require treatment for burn injuries experience substantial immune 
dysregulation. Presence of a concomitant injury or complicated event associated with the burn 
injury can significantly disturb immune homeostasis and result in altered healing and poor 
outcomes among patients. Many studies have focused on burn-associated immune dysregulation, 
and the field is currently expanding to include research on additional comorbidities of burn 
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injury. In addition to the comorbidities discussed here, additional research is needed to study the 
combined effects of burn and radiation [41, 145, 146], the effects of sex in responses to burn 
[147, 148], burn associated with diabetes [85, 149, 150], and the presence of multiple 
simultaneous comorbidities [44]. 
The innate arm of the immune system is altered after burn injury, and comorbidities 
commonly promote further dysregulation of innate immunity. Multiple studies have indicated 
that immune cells of myeloid lineage are dysregulated in response to burn injury. Burn injury 
leads to altered recruitment of neutrophils to the pulmonary compartment, as well as altered 
hematopoiesis. Neutrophils are a powerful cell type that is responsible for protecting the body 
from bacterial insult[151]. Studies have shown that neutrophils are both necessary and sufficient 
to clear multiple bacterial pathogens [152, 153], and dysfunction of the myeloid arm of the 
immune system is commonly associated with comorbidities of burn injury.  
In Chapters 2-4 we discuss unique models that we have generated in our laboratory 
to study burn and its associated comorbidities of inhalation injury and infection.  We have 
utilized these models to assess potential molecular mechanisms involved in burn-associated 
diseases, focusing on the role that macrophages and neutrophils play in recovery after burn 
injury. In the future, we plan to utilize these models to test potential therapeutics for improved 
outcome after burn injury.   
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CHAPTER 2: ONE-HIT WONDER: LATE AFTER BURN INJURY, GRANULOCYTES 





Objective: Many studies have described the acute immune response to burn injury in both human 
and animal models, yet few studies are able to recapitulate long term immune suppression and 
bacterial susceptibility seen in burn patients. We hypothesized that patients suffer immune 
exhaustion due to repeated microbial challenge, therefore single challenge in animal models will 
not recapitulate this clinical phenotype. Herein we describe a novel mouse model of repeated 
infection after burn injury, which reveals immune suppression resulting in decreased pulmonary 
clearance of bacteria. 
Methods: Wildtype mice receiving a full-thickness contact burn were infected with 
Pseudomonas aeruginosa 14 days and/or 17 days after burn or sham injury. Pulmonary 
macrophages and neutrophils were enumerated and evaluated for immune activation and 
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Results: In the double infection model, burn mice were unable to clear bacteria compared to 
sham injured or singly infected burn mice. After a second infection, neutrophils and 
macrophages recruited to the airways exhibited 1) reduced production of anti-bacterial reactive 
oxygen and nitrogen species, and 2) increased production of the anti-inflammatory cytokine 
interleukin-10 in the macrophage population compared to sham or singly infected burn mice.  
Conclusions: In our model, burn mice exhibited immunosuppression with specific perturbations 
in their pulmonary innate cell populations. This phenotype is similar to previously reported 






Burn injury causes significant lengthy hospital stays among patients. Every year 486,000 
patients in the United States seek medical attention for burn injury [1]. Burn injury commonly 
creates a significant wound that is slow to heal and causes significant immune dysregulation and 
immunosuppression. Patients that experience this immunosuppression often acquire additional 
associated complications such as colonization with nosocomial bacteria. Infection of burn 
patients is also commonly associated with increased morbidity and mortality; patients who have 
more than one incidence of bacterial infection during the course of their hospital stay can 
experience a 42% increase in mortality [2].  
Bacterial pneumonia is a leading cause of mortality among burn patients [3]. One 
common source of bacterial pneumonia within the burn patient population is Pseudomonas 
aeruginosa, a gram-negative opportunistic infection [4, 5]. Full clearance of pseudomonal 
infections requires the activation and integration of the immune system [6, 7]. Studies have 
demonstrated that neutrophils are the primary innate immune cells responsible for preventing and 
clearing bacterial infections, and that a neutrophil response is both necessary and sufficient for 
clearance of P. aeruginosa infections [8]. 
Immediately after burn injury patients experience a general activation of the immune 
response, with one model defining this as early systemic inflammatory response syndrome 
(SIRS) [9-11]. This response is typically associated with cytokine storm, immune cell 
proliferation and systemic immune cell recruitment [12]. Continual activation of the immune 
system leads to activation of a late compensatory anti-inflammatory response syndrome (CARS) 
[13]. Although many studies have demonstrated and examined the SIRS response in both human 
and animal models [14-19], few studies are able to recapitulate the CARS response seen in the 
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human population using animal models. In fact, multiple studies in animal models indicate that 
after injury, burn mice are more capable of responding to infection than their sham counterparts 
[20-26]. Recent studies indicate that the SIRS/CARS paradigm may not accurately represent the 
complex immune response in burn patients because pro- and anti- inflammatory mediators are 
often detected simultaneously [27-32] and patients experience a mixed antagonist response 
syndrome (MARS) at all time points. We retain the SIRCS/CARS terminology for this study to 
define the “early” and “late” phases after injury and the immune bias of the MARS response 
after burn injury.    
Additional studies indicate that SIRS and CARS among burn patients leads to release of 
immune cytokines and alterations in the immune profile, and that poor outcomes following 
infection within patient populations can be predicted by production of the cytokines interleukin 
10 (IL-10) and interleukin 12 (IL-12) [30, 33-36]. Additionally, murine studies have indicated 
that these cytokines play an important role in burn-associated responses to bacterial infection 
[14, 34, 37, 38]. Researchers have demonstrated that treatments resulting in decreased IL-10 
production after burn injury lead to increased bacterial clearance and improved outcome [14, 39, 
40] and that current therapeutic targets exist capable of altering cytokine production after burn 
injury [36]. These findings indicate that IL-10 and IL-12 are important markers and potential 
targets for therapeutic interventions.  
It is evident that there is an increased neutrophil presence in the lung vasculature early 
and late after burn injury [20-22]. Late after injury these neutrophils are part of the overall 
heightened immune response and can result in improved outcome in burn mice following single 
infection [20, 21], an effect that is lost with the elimination of the protective neutrophil 
population using anti-Ly6G antibodies [22].  These results present a unique case in which data 
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obtained from patients late after burn injury is not reflected in the animal model. We have 
additionally demonstrated that in the presence of burn-associated comorbidities such as 
irradiation or smoke exposure, infection with bacterial exposure can result in a loss of the 
protective effect of burn injury [41, 42].  
In a nosocomial environment, the skin microbiota of patients commonly changes to 
match that of their environment and the nurses with whom they commonly interact [43, 44]. 
Burn wounds represent a disrupted barrier to the environment, and burn patients have a high 
incidence of infection (39% in our burn unit) due to large burn wounds and necessary surgery, 
resulting in subsequent immune dysregulation [45-47]. In contrast, mice utilized in 
experimentation are housed in specific-pathogen free environments and are protected from 
bacterial exposure. We hypothesized that the pulmonary neutrophil population present after burn 
injury creates a protective environment in which mice are prepared to respond to an initial 
pulmonary infection with P. aeruginosa. However, we believe that this population represents a 
finite resource and that once activated to respond to a bacterial insult this short-lived population 
is unable to replenish and mount continual protection to repeated exposure to bacteria. We 
additionally predict that these cells may play an important role in the production of IL-10 and IL-
12 in vivo. 
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Material and methods 
Animals 
Female C57BL/6 mice aged eight to twelve weeks old, weighing >18 grams were 
purchased (Taconic Farms) and used for this study. Mice were shaved dorsally, given a 
subcutaneous injection of morphine (3mg/kg body weight, West-Ward Pharmaceuticals) and 
underwent a 20% total body surface area burn as previously described [14, 41, 48, 49]. A full-
thickness contact burn was achieved using a 65 gram copper rod (1.9 cm in diameter) that had 
been heated to 100°C and applied to the dorsum/flank for four applications, each lasting 10 
seconds. Animals were then placed in individual cages, given food and water ad libitum and 
monitored twice daily. All sham animals underwent the same procedure with the exception of the 
application of the burn injury. All animals were housed in a specific pathogen-free environment 
and all procedures were approved by the Institutional Animal Care and Use Committee at the 
University of North Carolina at Chapel Hill in accordance with NIH guidelines for the care and 
use of Laboratory animals (NIH Publications No. 8023, revised 1978). 
 
Bacterial Inocula preparation and infection 
A wildtype strain (PAK) of P. aeruginosa was utilized for all infections as previously 
described [14]. Bacteria from frozen cultures were grown overnight in Luria Broth (LB). The 
following morning cultures were diluted 50x and grown for approximately two hours until mid-
log phase growth was achieved (OD600=0.6-1.2). Cultures were then centrifuged at 14000 rpm 
for 30 seconds, and the pellet was washed using 1mL PBS+1% Protease Peptone solution 
(PBS+1%PP). Bacterial pellets were re-suspended and diluted to the desired concentration and 
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verified by optical density at 600nm. Bacterial concentration was then confirmed by serial 
dilution and plating on LB agar plates.  
 
 Mice infected intraperitoneally received a 1mL injection of P. aeruginosa at a 
concentration of 5x105 CFU/mL. Uninfected mice were given an intraperitoneal injection with 
1mL of PBS+1%PP as a control. Mice infected intratracheally were anesthetized with an 
intraperitoneal injection of Avertin (0.475mg/g body weight: Sigma-Aldrich). Mice were then 
placed on an intubation platform, and infected by visualization of the vocal cords with a 
laryngoscope (Model LS-2, Penn Century Inc.), and inserting a MicroSprayer® Aerosolizer 
(Model 1A-1C and FMJ-250 High-Pressure Syringe Penn Century, Inc.) through the vocal cords, 
after which a 50uL volume was aerosolized into their lungs using either a bacterial innocula 
(2x107 CFU/ML in PBS+1%PP) or vehicle (PBS+1%PP).  
 
Enumeration of bacteria 
At time of sacrifice, the left lobe of the liver, the lungs, and the spleen were removed and 
placed in 0.5mL of LB broth on ice. Tissues were homogenized using a BulletBlender (Next 
Advance) and three 3.2mm stainless steel beads per tube of tissue. Tissue homogenate was 
serially diluted and plated on LB agar for quantification. Plates were incubated overnight at 
37°C. 
 
BAL and Whole Lung tissue collection 
Bronchoalveolar lavage collection was performed on mice to obtain cells collected from 
the airway as previously described [50-52]. Mice were killed using administration of isoflurane 
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and a catheter (22G x 1”, Exel) was placed into the trachea and tied off. A syringe with 1mL 
0.6mM EDTA in PBS was connected to the catheter and 0.6 mL of the fluid was flushed into the 
lungs, the lungs were massaged, and then the fluid was withdrawn into the syringe to obtain a 
primary wash. This procedure was repeated three times. Two additional washes were performed. 
Samples were spun down for cellular analysis and the supernatant was collected for assay via 
Bradford assay and enzyme-linked immune-sorbent assay (ELISA). Lungs were removed from 
the animals and minced using sterile razor blades. Lungs were then placed in 4mL of PBS 
supplemented with 10% Fetal Bovine Serum (PBS+FBS), 0.1µg/mouse DNase, 1500 u/mouse 
collagenase and shaken at 250rpm at 37°C for 1h for digestion of tissue as previously described 
[14]. Samples were then filtered using a 100µm cell strainer and then pelleted. Pelleted cells then 
underwent ACK lysis for removal of red blood cells and then samples were washed and 
resuspended in PBS+FBS for staining for flow cytometric analysis. Cells collected from BAL 
and whole lung tissue were counted using a hemocytometer with 0.01% trypan blue viability 
dye.  
 
Flow cytometric analysis 
Cells were incubated with anti-mouse CD16/32 Block (eBiosciences) to block Fc 
receptors as previously described [14, 49]. Cells were then stained with antibodies against CD45, 
CD11c, CD11b, Ly6G, F4/80 and/or NOS2. Cells were then fixed in 1% paraformaldehyde and 
examined using a Dako CyAn (Beckmann-Coulter) and then data was analyzed using Summit 
software (Beckman-Coulter). Initial exclusion of CD45- cells was conducted, and then 
neutrophils (CD45+CD11b+CD11c-Ly6G+) and macrophages (CD45+CD11c+Ly6G-) were 
examined. To determine the potential of the neutrophils to produce reactive oxygen and nitrogen 
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species (RONS), analysis was performed using dihydrorhodamine-123 (DHR123). Samples were 
stained using fluorochrome-conjugated antibodies as previously stated. Prior to fixation in 
paraformaldehyde, the samples were resuspended in DHR123 (1.875 mg/mL, Invitrogen). The 
samples were then split into stimulated and unstimulated samples. Samples were stimulated 
using 98nm Phorbol myristate acetate (PMA) for 30 minutes at 25˚C in the dark. All samples 
were then fixed in a 1% paraformaldehyde solution, and analyzed using flow cytometry. 
Reactive Oxygen and Nitrogen Species (RONS) expression was determined for each cell 
population present, as previously described [53]. 
 
Statistical Analysis 
All data were visually displayed in GraphPad Prism Version 5.0 for Windows and 
analyzed by Student’s t-Test or One-Way Analysis of Variance (ANOVA) with a Tukey post-
test. Data are represented as mean+/- standard error of the mean (SEM). Statistical significance is 
indicated as * p < 0.05, ** p < 0.005, *** p < 0.001.   
 
Results  
Repeated infection leads to susceptibility to bacterial dissemination in a murine model of burn 
injury. 
 
Hospital stays frequently result in changes in the microbiome of patients and these 
changes commonly lead to development of hospital acquired infections [43, 45, 46]. Animal 
models of bacterial exposure often depend on a single exposure to bacteria, which is not 
representative of a nosocomial environment. To more closely mimic clinical conditions with 
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repeated bacterial exposure, we employed an infection strategy in which mice were initially 
infected (14 days after burn injury) intratracheally (IT) with P. aeruginosa, and then received a 
high-dose intraperitoneal (IP) infection with P. aeruginosa (17 days after burn injury). After a 
single IP infection, sham injured mice exhibited significant mortality and high, disseminated 
bacterial burden in the lungs and distal organs (Figure 2.1A). Administration of an initial IT 
infection 3 days prior to the IP infection reversed this phenotype and protected the sham mice 
from death (Figure 2.1A). In contrast, after a single IP infection, burn-injured mice experienced 
burn “priming” protection against a dose of bacteria that was fatal to sham counterparts, as 
predicted by earlier studies [20-22, 25, 26, 49] with significantly reduced bacterial dissemination 
(Figure 2.1B). However, burn mice that had an initial IT infection were unable to clear a 
secondary IP infection and demonstrated increased mortality and systemic bacterial burden 
(Figure 2.1C). This suggests that burn “priming” is transient, and a secondary infection causes 
burn-mediated immune protection to collapse in comparison with sham mice. 
 
Repeated infection leads to increased neutrophil and macrophage numbers in the lungs late after 
burn injury.  
 
To examine the potential underlying mechanism of burn-dependent alterations in immune 
response to bacterial infection in our double infection model, we examined changes in immune 
cells present in the infected tissue. We focused on the lungs because pulmonary infections are a 
common comorbidity and cause of mortality after burn injury. First, we examined the initial 
intratracheal (IT) response in isolation. 14 days after administration of sham or burn injury, mice 
were infected IT with P. aeruginosa. Live cells were enumerated from either BAL or whole lung 
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tissue to characterize burn-associated responses to a single IT bacterial infection 24 hours after 
infection; we observed a significant increase in the number of live cells in whole lung in sham 
and burn mice after IT infection (Figure 2.2A). Using specific flow cytometric quantification of 
innate immune cells in the lung (representative staining shown in Figure 2B), we found that there 
were no burn or infection-dependent changes in the total number of macrophages present in the 
BAL or whole lung tissue (Figure 2.2C and 2.2D). However, infection led to a marked increase 
in the numbers of neutrophils present in BAL collected from both sham and burn-injured mice 
(Figure 2.2E). Additionally, we found that infection led to an increased number of neutrophils 
present in the whole lung tissue collected in mice, a phenotype augmented by burn-injury (Figure 
2.2F). These data agree with earlier studies which demonstrate that an increased number of 
neutrophils are responsible for the burn “priming” after burn [14, 20, 22].  
In order to identify the cellular mechanism responsible for burn-mediated susceptibility 
to repeated bacterial exposure in our mouse model, we examined changes in innate cellular 
compartments after repeated bacterial infection. Burn or sham mice were initially infected (14 
days after burn injury) intratracheally (IT) with P. aeruginosa, and then received a high-dose 
intraperitoneal (IP) infection with P. aeruginosa (17 days after burn injury). We analyzed cells 
present in BAL and found that there was an infection-dependent increase in the number of 
neutrophils, and that the number of neutrophils was significantly higher in burn mice than in 
sham treated animals (Figure 2.3A). We additionally found that while infection of sham-treated 
animals did not alter macrophage levels in the BAL, burn injured mice experienced increased 
macrophage recruitment to BAL after priming with intratracheal infection (Figure 2.3B). These 
data collectively imply that both neutrophils and macrophages are recruited to the airways of 
animals that have been infected twice. 
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Neutrophils from burn mice are not able to be activated after secondary infection to increase 
RONS production.  
 
In addition, we sought to examine immune changes that took place in the actual tissue of 
the lungs. Enumeration of single cell suspensions generated from whole lung tissue found that 
there was an infection-dependent increase in the total number of neutrophils present in the tissue 
(Figure 2.3C). We additionally noted that there was an infection-dependent and injury-dependent 
change in the total number of macrophages present in the tissue of the whole lung, implying that 
macrophages could potentially mediate burn-dependent differences in response to infection 
(Figure 2.3D). We then examined macrophage and neutrophil function to determine their 
microbicidal potential. We utilized DHR123 to quantify the levels of RONS present in cells 
collected from whole lung tissue. We found that burn injury alone causes increased neutrophil 
RONS production as characterized by mean fluorescent intensity (Figure 2.4A&B). Additionally, 
we found that after burn animals are infected, basal RONS generation decreases, with doubly-
infected animals generating significantly decreased RONS relative to uninfected burn 
counterparts. We therefore hypothesized that diminishment of RONS production is the source for 
lost burn-mediated protection. We found nominal changes in macrophage RONS production 
(Figure 2.4C&D). Loss of RONS activity in neutrophils also correlates with changes in 
intracellular expression of inducible nitric oxide synthase (NOS2) (Figure 2.4E). Upon infection, 
sham control mice exhibit reduction of NOS2 intracellular expression compared to burn mice, 
which is partially recovered upon secondary infection. In contrast, NOS2 expression was not 
changed in burn mice after an initial infection but was decreased upon subsequent infection. 
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Neutrophil and macrophage IL-10 and IL-12 are differentially expressed after single and double 
infections in burn mice.  
 
We have previously demonstrated that aberrant production of IL-10 and reduced IL-12 
cytokines is likely a major factor contributing to the immunopathology responsible for 
susceptibility to infection in burn patients [14, 30, 33, 34, 36].  We examined production of anti-
inflammatory cytokine IL-10 and pro-inflammatory IL-12 in the macrophage and neutrophil 
populations in our model of double infection after burn injury. We collected BAL from animals 
24 hours following single or double bacterial infection. Using flow cytometry, we found that 
intracellular IL-10 levels in neutrophils were significantly increased after burn injury or single 
infection compared to sham animals (Figure 2.5A) with a significant decrease after double 
infection in burn mice compared to single infection. In contrast, only double infection led to an 
increase in production of IL-10 in the macrophage population in burn-injured mice (Figure 
2.5B). When we examined intracellular levels of IL-12 we found that neutrophils from singly 
infected burn mice exhibited a significant increase in IL-12 compared to sham controls (Figure 
2.5C), which may act as a cellular mechanism for burn “priming” (Figure 2.1). This expression 
was abolished on double infection (Figure 2.5C).  There was no increase after burn alone, single 
infection or double infections in burn macrophages (Figure 2.5D). Taken together, these data 
highlight a new finding; that there is differential expression of pro- and anti- inflammatory 
cytokines by macrophage and neutrophil populations on secondary bacterial challenges. These 
data recapitulate and provide a possible cellular mechanism for our previous findings that 
elevated IL-10 and decreased IL-12 predict increased infection rates, and poor clinical outcome 
in patients [30, 36]. 
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Discussion 
Murine models are frequently utilized to examine molecular and cellular mechanisms of 
burn-associated immune dysfunction [14, 49, 54-56]. However, clinically relevant animal model 
of injury should recapitulate phenotypes seen among human patients. Multiple studies have 
indicated that current murine models of burn injury are insufficient to elicit immunosuppression 
late after burn injury [20, 57]. In our model burn mice required repeated exposure to bacterial 
insult in order for burn-mediated immunosuppression to become apparent. This phenotype is 
similar to previously reported clinical data. Previous studies have indicated that mortality is only 
significantly increased among the burn population after a secondary bacterial challenge [2]. This 
clinical result in conjunction with our data implies that the immune compartment is sufficient to 
protect patients against a single bacterial insult, but that a second infection will result in 
immunosuppression.  
We hypothesized that immune cells that respond to repeated infection would exhibit 
immune cell exhaustion and that they would be therefore unable to mount appropriate immune 
responses to subsequent infection. To characterize immune exhaustion, we examined immune 
cells present as well as their cellular function. We found that burn injury resulted in increased 
numbers of neutrophils present in whole lung tissue collected from mice. Neutrophils are 
recruited to the lungs after injury, and represent a pool of innate immune cells that could rapidly 
respond to any bacterial insult in the lung compartment. Neutrophils function by production of 
multiple mediators, such as RONS, in order to destroy bacterial pathogens and have been found 
to be necessary and sufficient to resolve infection with P. aeruginosa [6, 8]. We postulated that 
the recruited neutrophil population would represent a finite resource, and that after initial 
immune activation and use of the neutrophil reservoir any innate immune cells later recruited to 
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the compartment would experience immune cell exhaustion. Upon initial examination we found 
that despite the presence of neutrophils in whole lung tissue, a single intratracheal infection 
resulted in comparable recruitment of cells to the airspace in both sham and burn-treated 
animals. We also found that intratracheal infection resulted in recruitment of cells to the whole 
lung tissue, with slightly elevated numbers of neutrophils present in the whole lung tissue of 
burn-treated animals. Increased neutrophil numbers in the lungs correlated with improved 
bacterial clearance in burn mice after a single infection when compared to their sham-injured 
counterparts. Upon subsequent infection, sham mice “catch up” by recruiting more neutrophils to 
combat infection; functionally we do not observe any difference between RONS or cytokine 
production between the first and second infection. In contrast, the neutrophils recruited to 
combat a second infection late after burn injury produce less RONS and IL-12 than those that 
were recruited after the first bacterial hit. These results support our hypothesis that despite burn-
induced “priming” the immune system is unable to mount a successful immune response to a 
secondary bacterial exposure.  
Upon infection of a host, bacterial agents such as P. aeruginosa will release pathogen 
associated molecular patterns (PAMPS) that are able to alter the immune response. Multiple 
studies have indicated that the presence of PAMPS in a host is sufficient to result in altered 
immune cell signaling, cytokine production and changes in RONS-associated machinery [58, 
59]. Studies have additionally indicated that burn injury leads to increased RONS and pro-
inflammatory cytokine production in immune cells which can mediate additional tissue injury 
[60-63]. Some studies have indicated that it is possible to decrease RONS activity shortly after 
burn injury and decrease damage to lungs while still permitting successful clearance of 
subsequent infection [62], and other studies have implicated neutrophils as the only innate cell 
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type responsible for burn-mediated hyperactivity [20, 22]. In this study we report increased total 
numbers of macrophages and neutrophils present in the whole lung tissue after burn injury 
repeated infection. We additionally found that burn injury increased basal RONS and pro- and 
anti- inflammatory cytokine activity of neutrophils, but that upon repeated infection this was lost. 
We also found that upon each incidence of infection these cells decreased their baseline 
production of RONS. Repeated incidence of infection would cause cells to be repeatedly exposed 
to PAMPS and result in changes in intracellular signaling leading to changes in RONS 
production.  We have previously demonstrated that increased production of IL-10 and reduced 
IL-12 cytokines from several pulmonary and systemic cell types, including macrophages and 
neutrophils, is a major factor contributing to the immunopathology responsible for susceptibility 
to infection in burn patients [14, 30, 33, 34, 36].  We have also demonstrated the prognostic 
potential of IL-10/IL-12 protein ratios within bronchial washes on predicting lung and systemic 
infections following severe burn trauma [14, 30, 36]. We report here that that there is differential 
expression of pro- and anti- inflammatory cytokines by macrophage and neutrophil populations 
which are significantly different on secondary bacterial challenges. Although macrophages from 
burn mice did not have any apparent change in RONS production after burn or infections, they 
exhibited a significant increase in IL-10 production after a secondary bacterial infection. These 
data suggest that macrophages might “guide” subsequent immune responses in the pulmonary 
micro-environment and warrants further investigation. Multiple studies have indicated that 
cytokines play an important role in patient immune responses, and we have found that levels of 
IL-10 and IL-12 are predictive of outcomes after burn injury [30, 36]. Our study indicates that 
burn and infection alter innate immune cell production of IL-10 and IL-12. Moreover, our 
preliminary investigations suggest a relationship between peripheral blood IL-10/IL-12 and 
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arginase 1 gene (ARG1)/NOS2 gene expression ratios and indicate that they have a powerful 
predictive ability for susceptibility to infection in burn patients. When we examined neutrophil 
levels of NOS2 we found that infection of sham-injured mice resulted in decreased NOS2 
expression. This phenotype was not found in burn injured-mice after a single exposure to P. 
aeruginosa, however loss of NOS2 levels took place after repeated infection, potentially 
indicative of exhaustion arising in burn-injured mice and associated loss of burn-mediated 
protection. 
 
We and others have previously reported that cells from burn-injured animals exhibit 
altered signaling of toll-like receptors (TLRs), the receptors responsible for detection of PAMPS 
and subsequent activation of the immune system [14, 34, 47, 64, 65]. Alteration of TLR function 
after burn injury have additionally been shown to lead to alterations in cytokine production in a 
model of burn injury [66]. It is possible that alterations in innate immune cell TLR levels result 
in alterations in the immune response, production of cytokines, and subsequent response to 
bacterial infection. Future studies will establish the link between TLR signaling and 









Figure 2.1: Repeated, but not single infection, leads to susceptibility to bacterial infection in 
a murine model of burn injury. Mice (n=4-6 per group) underwent sham or burn injury and 
were infected with either A) intraperitoneal (IP) infection with P. aeruginosa 17 days after injury 
(ShamP); or intratracheal (IT) inoculum of P. aeruginosa 14 days after injury and a subsequent a 
IP infection with P. aeruginosa 17 days after injury (ShamT/P ); B) IP infection with P. 
aeruginosa 17 days after injury (ShamP or BurnP); or C)  IT with P. aeruginosa 14 days after 
injury, followed by IP infection with P. aeruginosa 17 days after injury (ShamT/P or BurnT/P). 
Survival was monitored for up to 96 hours after final infection. Lungs, liver and spleen were 
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harvested from surviving mice for P. aeruginosa quantification by colony forming unit (CFU) 
analysis. Dashed line represents lower limit of detection for the CFU assay. Data shown are +/-
SEM.  *p<0.05, **p<0.01, and representative of three repeated experiments. Numbers of initial 





Figure 2.2: Single IT infection leads to increased neutrophil numbers in the lung BAL late 
after burn injury.  Mice (N=4-6 per group)  underwent sham or burn injury and were infected 
(14 days after burn injury) IT with P. aeruginosa (ShamT or BurnT) or uninfected (Sham or 
Burn) and lungs harvested 24 hours later; A) total cells enumerated counted on a 
haemocytometer, B) representative flow cytometry of BAL or whole lung tissue used to identify 
neutrophils and macrophages; cells are shown after gating on live singlets and common 
leucocyte CD45+ marker; C-F) number of macrophages or neutrophils from either BAL or 
whole lung were quantified for each injury and infection group.  Data shown are +/-SEM.  
*p<0.05, **p<0.01, and representative of three repeated experiments. Numbers of mice in 
representative figures; A, C-F), Sham, n=4; ShamT, n=4; Burn, n=4; BurnT, n=4. 
 
 
Figure 2.3: Double infection leads to increased neutrophil and macrophage numbers in the 
lung late after burn injury.  Mice (N=4-6 per group) underwent sham or burn injury and were 
given IT inoculation with PBS+1%PP or with P. aeruginosa (ShamT/P or BurnT/P) 14 days after 
injury, followed by IP infection IP with P. aeruginosa (ShamP or BurnP) at 17 days after injury,  
or left uninfected (Sham or Burn). Lungs were harvested 24 hours later; A-D) number of 
macrophages or neutrophils from either BAL or whole lung were quantified for each injury and 
infection group.  Data shown are +/-SEM.  *p<0.05, **p<0.01, ***p<0.005 and representative of 
three repeated experiments. Numbers of mice in representative figures; A-D), Sham, n=5; 





Figure 2.4: Neutrophils from burn mice are not able to be activated after secondary 
infection to increase RONS production.  Mice (N=4-6 per group) underwent sham or burn 
injury and were infected (17 days after injury) either IP with P. aeruginosa (ShamP or BurnP) or 
IT with P. aeruginosa 14 days after injury followed by IP infection at 17 days after injury 
(ShamT/P or BurnT/P), or left uninfected (Sham or Burn). Lungs were harvested 24 hours later; A-
C) reactive oxygen / nitrogen oxidative (RONS) ability per cell was measured by flow cytometry 
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in the absence or presence of Phorbol myristate acetate (PMA) stimulation (“+Stim.”), D) NOS2 
expression per cell was quantified in neutrophils using flow cytometry. Data shown are +/-SEM.  
*p<0.05, **p<0.01, and representative of three repeated experiments. Numbers of mice in 





Figure 2.5: Neutrophil and macrophage IL-10 and IL-12 are differentially expressed after 
single and double infections in burn mice.  Mice (N=4-6 per group) underwent sham or burn 
injury and were infected (17 days after injury) either IP with P. aeruginosa (ShamP or BurnP) or  
IT with P. aeruginosa 14 days after injury followed by IP infection at 17 days after injury 
(ShamT/P or BurnT/P), or left uninfected (Sham or Burn). Lungs were harvested 24 hours later; A-
D) intracellular IL-10 and IL-12 expression per cell was measured by flow cytometry (MFI). 
Data shown are +/-SEM.  *p<0.05, **p<0.01, ***p<0.005 and representative of three repeated 
experiments. Numbers of mice in representative figures; A-D), Sham, n=4; ShamP, n=5; ShamT/P, 





1. Branch, T.A.a.H.C.S. National Hospital Ambulatory Medical Care Survey: 2011 
Emergency Department Summary Tables. 2011  [cited 2017 November 7th]; Available 
from: https://www.cdc.gov/nchs/ahcd/web_tables.htm#2011. 
2. Mueller, E.W., et al., Effect from multiple episodes of inadequate empiric antibiotic 
therapy for ventilator-associated pneumonia on morbidity and mortality among critically 
ill trauma patients. J Trauma, 2005. 58(1): p. 94-101. 
3. Shupp, J.W., et al., Epidemiology of bloodstream infections in burn-injured patients: a 
review of the national burn repository. J Burn Care Res, 2010. 31(4): p. 521-8. 
4. Sousa, D., et al., Microbiology in burns patients with blood stream infections: trends over 
time and during the course of hospitalization. Infect Dis (Lond), 2017: p. 1-8. 
5. van Duin, D., et al., Timeline of health care-associated infections and pathogens after burn 
injuries. Am J Infect Control, 2016. 
6. Rada, B., Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic 
Fibrosis. Pathogens, 2017. 6(1). 
7. Lovewell, R.R., Y.R. Patankar, and B. Berwin, Mechanisms of phagocytosis and host 
clearance of Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol, 2014. 306(7): 
p. L591-603. 
8. Lavoie, E.G., T. Wangdi, and B.I. Kazmierczak, Innate immune responses to Pseudomonas 
aeruginosa infection. Microbes Infect, 2011. 13(14-15): p. 1133-45. 
9. Fontaine, M., et al., Innate danger signals in acute injury: From bench to bedside. Anaesth 
Crit Care Pain Med, 2016. 35(4): p. 283-92. 
10. Rogobete, A.F., et al., The influence of metabolic imbalances and oxidative stress on the 
outcome of critically ill polytrauma patients: a review. Burns Trauma, 2017. 5: p. 8. 
11. Dahiya, P., Burns as a model of SIRS. Front Biosci (Landmark Ed), 2009. 14: p. 4962-7. 
12. Chaudhry, H., et al., Role of cytokines as a double-edged sword in sepsis. In Vivo, 2013. 
27(6): p. 669-84. 
13. Ward, N.S., B. Casserly, and A. Ayala, The compensatory anti-inflammatory response 
syndrome (CARS) in critically ill patients. Clin Chest Med, 2008. 29(4): p. 617-25, viii. 
14. Neely, C.J., et al., Flagellin treatment prevents increased susceptibility to systemic bacterial 
infection after injury by inhibiting anti-inflammatory IL-10+ IL-12- neutrophil 
polarization. PLoS One, 2014. 9(1): p. e85623. 
46 
15. Rae, L., P. Fidler, and N. Gibran, The Physiologic Basis of Burn Shock and the Need for 
Aggressive Fluid Resuscitation. Crit Care Clin, 2016. 32(4): p. 491-505. 
16. O'Dea, K.P., et al., Circulating Microvesicles Are Elevated Acutely following Major Burns 
Injury and Associated with Clinical Severity. PLoS One, 2016. 11(12): p. e0167801. 
17. Liu, Y.W., et al., Activation of Adenosine 2A receptor inhibits neutrophil apoptosis in an 
autophagy-dependent manner in mice with systemic inflammatory response syndrome. Sci 
Rep, 2016. 6: p. 33614. 
18. Xu, Y.C., C.Q. Luo, and X. Li, Systemic inflammatory response syndrome following burns 
is mediated by brain natriuretic peptide/natriuretic peptide A receptor-induced shock factor 
1 signaling pathway. Clin Exp Pharmacol Physiol, 2016. 43(10): p. 921-9. 
19. Burmeister, D.M., et al., Impact of Isolated Burns on Major Organs: A Large Animal 
Model Characterized. Shock, 2016. 46(3 Suppl 1): p. 137-47. 
20. Gardner, J.C., et al., G-CSF drives a posttraumatic immune program that protects the host 
from infection. J Immunol, 2014. 192(5): p. 2405-17. 
21. Huber, N.L., et al., Prior thermal injury accelerates endotoxin-induced inflammatory 
cytokine production and intestinal nuclear factor-kappaB activation in mice. J Burn Care 
Res, 2012. 33(2): p. 279-85. 
22. Noel, G., et al., Neutrophils, not monocyte/macrophages, are the major splenic source of 
postburn IL-10. Shock, 2011. 36(2): p. 149-55. 
23. Alexander, J.W., Effect of thermal injury upon the early resistance to infection. J Surg Res, 
1968. 8(3): p. 128-37. 
24. Noel, G., et al., A ribonucleotide reductase inhibitor reverses burn-induced inflammatory 
defects. Shock, 2010. 34(5): p. 535-44. 
25. Stieritz, D.D. and I.A. Holder, Experimental studies of the pathogenesis of infections due 
to Pseudomonas aeruginosa: description of a burned mouse model. J Infect Dis, 1975. 
131(6): p. 688-91. 
26. Pinto, M. and T. Zehavi-Willner, Thermal injury-induced non-specific resistance to fatal 
Pseudomonas aeruginosa burn-infection in mice. Jpn J Exp Med, 1989. 59(5): p. 189-96. 
27. Finnerty, C.C., et al., Temporal cytokine profiles in severely burned patients: a comparison 
of adults and children. Mol Med, 2008. 14(9-10): p. 553-60. 
28. Jeschke, M.G., et al., Long-term persistance of the pathophysiologic response to severe 
burn injury. PLoS One, 2011. 6(7): p. e21245. 
29. Jones, S.W., et al., Bronchoscopy-derived correlates of lung injury following inhalational 
injuries: a prospective observational study. PLoS One, 2013. 8(5): p. e64250. 
47 
30. Maile, R., et al., Association between early airway damage-associated molecular patterns 
and subsequent bacterial infection in patients with inhalational and burn injury. Am J 
Physiol Lung Cell Mol Physiol, 2015. 308(9): p. L855-60. 
31. Mendoza, A.E., et al., Burn injury induces high levels of phosphorylated insulin-like 
growth factor binding protein-1. Int J Burns Trauma, 2013. 3(4): p. 180-9. 
32. Xiao, W., et al., A genomic storm in critically injured humans. J Exp Med, 2011. 208(13): 
p. 2581-90. 
33. Chen, W., et al., Ethyl pyruvate reverses development of Pseudomonas aeruginosa 
pneumonia during sepsis-induced immunosuppression. Int Immunopharmacol, 2017. 52: 
p. 61-69. 
34. Rani, M., et al., Damage-associated molecular patterns (DAMPs) released after burn are 
associated with inflammation and monocyte activation. Burns, 2017. 43(2): p. 297-303. 
35. Tsurumi, A., et al., TNF-alpha/IL-10 Ratio Correlates with Burn Severity and May Serve 
as a Risk Predictor of Increased Susceptibility to Infections. Front Public Health, 2016. 4: 
p. 216. 
36. Eitas, T.K., et al., Differential regulation of innate immune cytokine production through 
pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in 
burn patient immune cells and monocytes. PLoS One, 2017. 12(9): p. e0184164. 
37. Souza, H.R., et al., Heterogeneity of mast cells and expression of Annexin A1 protein in a 
second degree burn model with silver sulfadiazine treatment. PLoS One, 2017. 12(3): p. 
e0173417. 
38. Alexis, A., et al., Immune responses in relation to the type and time of thermal injury: an 
experimental study. Injury, 2015. 46(2): p. 227-32. 
39. Argenta, A., et al., Local Application of Probiotic Bacteria Prophylaxes against Sepsis and 
Death Resulting from Burn Wound Infection. PLoS One, 2016. 11(10): p. e0165294. 
40. Laghaei, P., et al., Immunogenicity and protective efficacy of Pseudomonas aeruginosa 
type a and b flagellin vaccines in a burned mouse model. Mol Immunol, 2016. 74: p. 71-
81. 
41. Mendoza, A.E., et al., Radiation combined with thermal injury induces immature myeloid 
cells. Shock, 2012. 38(5): p. 532-42. 
42. Murphy, T.J., et al., Linking the "two-hit" response following injury to enhanced TLR4 
reactivity. J Leukoc Biol, 2005. 77(1): p. 16-23. 
43. Lax, S., et al., Bacterial colonization and succession in a newly opened hospital. Sci Transl 
Med, 2017. 9(391). 
48 
44. Sanon, M.A. and S. Watkins, Nurses' uniforms: How many bacteria do they carry after one 
shift? J Public Health Epidemiol, 2012. 4(10): p. 311-315. 
45. Posluszny, J.A., Jr., et al., Surgical burn wound infections and their clinical implications. J 
Burn Care Res, 2011. 32(2): p. 324-33. 
46. Hazeldine, J., P. Hampson, and J.M. Lord, The diagnostic and prognostic value of systems 
biology research in major traumatic and thermal injury: a review. Burns Trauma, 2016. 4: 
p. 33. 
47. D'Arpa, P. and K.P. Leung, Toll-Like Receptor Signaling in Burn Wound Healing and 
Scarring. Adv Wound Care (New Rochelle), 2017. 6(10): p. 330-343. 
48. Dunn, J.L., et al., Direct detection of blood nitric oxide reveals a burn-dependent decrease 
of nitric oxide in response to Pseudomonas aeruginosa infection. Burns, 2016. 
49. Linz, B.M., et al., Innate Immune Cell Recovery Is Positively Regulated by NLRP12 
during Emergency Hematopoiesis. J Immunol, 2017. 198(6): p. 2426-2433. 
50. Kebaier, C., et al., Staphylococcus aureus alpha-hemolysin mediates virulence in a murine 
model of severe pneumonia through activation of the NLRP3 inflammasome. J Infect Dis, 
2012. 205(5): p. 807-17. 
51. Livraghi, A., et al., Airway and lung pathology due to mucosal surface dehydration in 
{beta}-epithelial Na+ channel-overexpressing mice: role of TNF-{alpha} and IL-
4R{alpha} signaling, influence of neonatal development, and limited efficacy of 
glucocorticoid treatment. J Immunol, 2009. 182(7): p. 4357-67. 
52. Yamada, M., et al., Interferon-gamma production by neutrophils during bacterial 
pneumonia in mice. Am J Respir Crit Care Med, 2011. 183(10): p. 1391-401. 
53. Leutner, S., A. Eckert, and W.E. Muller, ROS generation, lipid peroxidation and 
antioxidant enzyme activities in the aging brain. J Neural Transm (Vienna), 2001. 108(8-
9): p. 955-67. 
54. Abdullahi, A., S. Amini-Nik, and M.G. Jeschke, Animal models in burn research. Cell Mol 
Life Sci, 2014. 71(17): p. 3241-55. 
55. Williams, F.N., D.N. Herndon, and M.G. Jeschke, The hypermetabolic response to burn 
injury and interventions to modify this response. Clin Plast Surg, 2009. 36(4): p. 583-96. 
56. Sayeed, M.M., Inflammatory/cardiovascular-metabolic responses in a rat model of burn 
injury with superimposed infection. Shock, 2005. 24 Suppl 1: p. 40-4. 
57. Maung, A.A., et al., Injury enhances resistance to Escherichia coli infection by boosting 
innate immune system function. J Immunol, 2008. 180(4): p. 2450-8. 
49 
58. Okamoto, T., et al., Multiple contributing roles for NOS2 in LPS-induced acute airway 
inflammation in mice. Am J Physiol Lung Cell Mol Physiol, 2004. 286(1): p. L198-209. 
59. Mittal, M., et al., Reactive oxygen species in inflammation and tissue injury. Antioxid 
Redox Signal, 2014. 20(7): p. 1126-67. 
60. Han, S., et al., ROS-Mediated NLRP3 Inflammasome Activity Is Essential for Burn-
Induced Acute Lung Injury. Mediators Inflamm, 2015. 2015: p. 720457. 
61. Parihar, A., et al., Oxidative stress and anti-oxidative mobilization in burn injury. Burns, 
2008. 34(1): p. 6-17. 
62. Miyazaki, H., et al., Burn-Evoked Reactive Oxygen Species Immediately After Injury are 
Crucial to Restore the Neutrophil Function Against Postburn Infection in Mice. Shock, 
2015. 44(3): p. 252-7. 
63. Kasten, K.R., et al., Divergent adaptive and innate immunological responses are observed 
in humans following blunt trauma. BMC Immunol, 2010. 11: p. 4. 
64. Kaufman, T., et al., Nucleosomes and neutrophil extracellular traps in septic and burn 
patients. Clin Immunol, 2017. 
65. Cairns, B., et al., Increased Toll-like receptor 4 expression on T cells may be a mechanism 
for enhanced T cell response late after burn injury. J Trauma, 2006. 61(2): p. 293-8; 
discussion 298-9. 
66. Cairns, B.A., et al., Toll-like receptor 2 and 4 ligation results in complex altered cytokine 




CHAPTER 3: DEVELOPMENT AND METHODOLOGY OF A CLINICALLY-
RELEVANT MURINE MODEL OF INHALATION INJURY3  
 
SUMMARY 
Inhalation injury represents a significant comorbidity of burn injury that currently 
remains understudied. In order to assess the inhalation-dependent alterations that take place after 
burn injury, our lab has created a murine model of inhalation injury. Herein we describe the use 
of clinically-relevant particle board as a smoke source to create a laboratory-controlled system 
that can be utilized to assess many different scientific questions. In this chapter of the thesis we 
describe in detail how to utilize and replicate this model for use in other systems, focusing on the 
overall methodology and requirements involved. 
  
                                                          
3 This chapter contains methodology that is intended to be utilized for submission in the future. 
This is the author’s original work. The current authors, in order: Kartchner LB, Mac M, Shyng 
BJ, Dunn JLM, Maile R, Cairns BA.  
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INTRODUCTION  
Burn injury represents a severe form of trauma that leads to lengthy hospital stays and 
slow healing among patients. Patients who present to the hospital with burn injuries often 
experience significant systemic immune dysregulation [1-4]. Large wounds present on epithelial 
tissue lead to a systemic release of damage-associated molecular patterns (DAMPS) that are 
known to markedly impair the immune compartment and lead to activation of the immune 
system as characterized by altered levels of cytokines, chemokines, and immune cells in patients 
[5]. Burn injury leads to an overwhelming shock response that is characterized by the presence of 
DAMPS, cytokine storm, and abnormal immune cell profiles.  
Immune dysregulation in burn patients is often complicated by the presence of a burn-
associated comorbidity. For example, approximately 10-20% of burn patients are diagnosed with 
a burn-associated inhalation injury [6], which can result in a 20% increase in mortality relative to 
patients who experience a burn injury alone [7-9]. This has led to inhalation injury being a 
leading cause of burn-associated mortality [10, 11]. Over time, many animal models of 
inhalation injury have been created to examine inhalation-mediated alterations in the immune 
profile [12-14], however few advances in the treatment of inhalation injury have been generated 
[6]. This could potentially be due to the lack of models that examine the combined effects of 
burn and inhalation injury [15], or due to a lack of clinically relevant smoke sources as many 
inhalation injury models depend on smoke generated from cotton [16, 17]. 
Here, we describe a novel model for the study of inhalation injury, wherein we use 
clinically relevant sources for the generation of wood smoke. We additionally describe the steps 




The following protocols were approved by the Institutional Animal Care and Use Committee 
at the University of North Carolina at Chapel Hill and comply with current standards for animal 
care and use as defined by the National Institutes of Health. All mice were purchased from 
Taconic Farms, aged 8-10 weeks old, and housed in specific pathogen free facilities. 
 
1. Creation of woodsmoke apparatus 
1. Purchase particle board in a lot size large enough for the completion of all 
experiments necessary. 
2. Cut the particle board into segments that are approximately 2.5cm x 8cm in size, 
excluding any pieces that have residual paint for consistency. Store any extra 
particle board in a sealable storage bag to prevent humidification of wood. 
3. Obtain a hot plate stirrer that can be heated to 500°C (VWR, #12365-382), a side-
arm flask (Fisher Scientific, #FB3002000), rubber tubing (Fisher Scientific #14-
178D), 2mL serological pipette tip (Corning, #4486) with cotton filter removed, 
one-hole rubber stopper (Fisher Scientific, #14135N), induction chamber 
(Stoelting Co., #50216), a small/flat plastic platform approximately 8.5cm x 13cm 
and Velcro strips. 
4. Place Velcro strips on the small plastic platform to create a device meant to hold 
an anesthetized mouse in place. 
5. Place the hot plate in a designated fume hood and place the flask on the hot plate.  
6. Insert the 2mL serological pipette into the one-hole rubber stopper and place the 
stopper on the flask. 
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7. Use rubber tubing to connect the 2mL serological pipette to the airflow valve of 
the hood. 
8. Using approximately 40cm of rubber tubing, connect the side arm of the flask to 
the clear induction chamber utilized, with the chamber turned on its long side. 
9. Final setup of the apparatus should reflect that shown in figure 3.1. 
2. Preparation of mouse for exposure. 
1. Mice are initially weighed and anesthetized with tribromoethanol (475mg/kg; 
Sigma-Aldrich). 
2. In order to provide consistency for comparison of experiments where a burn 
injury takes place, shave the dorsum of the mouse and then administer a 
subcutaneous injection with morphine sulfate (3mg/kg; Westward 
Pharmaceuticals).  
3. Place a cannula (22G x 1”, Exel) on a blunted and shortened needle to provide 
structural support. 
4. Place mice in a supine position on an intubation platform (Penn Century). 
5. Visualize the trachea with a laryngoscope (Penn Century). 
6. Insert the previously prepared cannula through the vocal chords and into the 
trachea. Remove the blunted needle from the catheter. 
7. Carefully remove mouse from intubation platform without displacing the cannula 
while maintaining supine orientation. 
8. Secure the mouse in place using the Velcro-strip platform previously made in 
order to provide support to the mouse. 
3. Performing Inhalation Injury 
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1. Preheat the flask to 500°C. 
2. Weigh approximately 18g of previously charred particle board and approximately 
30g new particle board and place into flask while air is applied pumped into the 
system. Weigh any new wood that is placed into the system to determine the final 
weight of wood used for the experiment. 
3. Keep air pressure applied to the system constant throughout the experiment.  
4. Once smoke has reached appropriate density, disconnect tubing to the induction 
chamber and open the chamber door to allow full clearance of smoke in the 
chamber. 
5. Place the previously intubated mouse into the induction chamber. 
6. Close the door and reconnect the tubing to the chamber. 
7. Expose the mouse to smoke for two minutes.  
i. As smoke is applied, visually assess the exposure. Breathing of mice 
should continue throughout the exposure. Breathing should also create 
what appear to be “inverse smoke rings,” where air being breathed out 
from the mouse is cleared of smoke. 
ii. If necessary, to ensure consistency of smoke density it is acceptable to 
slightly vent the chamber. Ideal exposure will result in smoke creating a 
visual obstruction at 1-1.5 inches from the chamber door, allowing for 
visualization of the mouse head. 
8. Disconnect tubing from the chamber and open the chamber door to allow full 
clearance of smoke in the chamber and expose the mouse to fresh air for one 
minute. 
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9. Repeat steps 7 and 8 two more times, in order to allow three exposures total. 
10. After exposure of the mouse, assess the breathing of the mouse. If assistance is 
necessary, continual movement of the mouse in the hands of the experimenter will 
improve respiration. 
11. Following procedure place the mouse on a heating pad to ensure maintenance of 
body temperature while under anesthesia. 
12. After the mouse has woken, administer an intraperitoneal injection with lactated 
Ringer’s solution (1mL/kg body weight; Baxter Healthcare Incorporated), and 
place the mouse in a cage for short-term monitoring prior to return to the animal 
facility. 
13. Mice can be given morphine water in their drinking water ad libitum for the 
duration of the experiment in order to ensure similarity with treatment of burn-
injured animals, and also ability to compare results found in these studies with 
those of patients who receive inhalation injury. 
14. Monitor mice throughout the course of the experiment. 
Discussion 
 Patients who experience an inhalation injury experience significant deterioration of their 
health and have worsened overall outcomes when compared to healthy individuals. Additionally, 
inhalation injury causes marked increases in mortality among burn patients and represents an 
important area of study. In this chapter of this thesis we describe a fully-developed model of 
inhalation injury for study using a murine model. This model will allow for further studies 
focusing on the metabolic, immune, pulmonary, and other systems that are affected by inhalation 
injury. In chapter 4 of this thesis we describe the use of this model to characterize the pulmonary 
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immune response to a combined burn and inhalation injury model. These models are critically 
important in the discovery of mechanistic underpinnings of inhalation injury-mediated disease, 
as well as a powerful tool for testing of potential therapeutics that can be used in clinical studies 






Figure 3.1: Experimental setup for successful generation of inhalation injury of murine 
animals. Mice are anesthetized, shaved, given morphine, incubated and placed on platform in 
chamber where they are exposed to smoke generated from particle board sections that smolder in 
a side-arm flask on a hotplate. Each mouse receives three exposures to the smoke, with each 
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CHAPTER 4: IMMUNE-MEDIATED MECHANISMS OF PULMONARY DAMAGE 
AFTER BURN AND INHALATION INJURIES INDEPENDENTLY LEAD TO 
DAMAGE GENERATED3  
 
Overview 
Inhalation injury is commonly associated with burn injury and leads to significant 
increases in morbidity and mortality among burn patients. In this study we utilize a murine 
model of burn and inhalation injury to examine the individual and combinatory effects of each 
individual injury and their effects on the pulmonary innate immune system. We found that 
combined injury, but not inhalation or burn injury alone, resulted in significantly increased 
mortality. Inhalation injury led to an increase in the total number of cells present in the airways 
of animals, and that increases in cells also corresponded with increases in protein concentration. 
Increased numbers of cells in the airways was largely attributable to neutrophil influx. We 
discovered inhalation-injury dependent alterations in levels of cytokines and chemokines present 
in the bronchoalveolar lavage obtained from injured mice, which correlated with functional 
changes in the levels of nitric oxide synthase in macrophages. Finally, we examined the potential 
therapeutic use of a nitric oxide inhibitor L-NAME and found that administration of L-NAME at 
the time of injury resulted in decreased total neutrophils present in airways, as well as decreased 
                                                          
4 This chapter contains a manuscript that is currently in preparation for submission. This is the 
author’s original work. The current authors, in order: Kartchner LB, Dunn JLM, Mac M, Shyng 
BJ, Glenn LI, Vaughan RJ, Maile R, Cairns BA. 
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protein levels. These findings could help guide future studies focused on treatment of patients 
afflicted with an inhalation injury. 
 
INTRODUCTION  
Burn injury results in significant loss of productivity among trauma patients [1]. Burn 
patients experience one of the most severe forms of trauma, often resulting in lengthy treatment 
and hospital stay [2]. Recovery of patients with a burn injury is often complicated by many 
factors such as total body surface area (TBSA) of injury, infection, presence of inhalation injury, 
modality of burn injury, concomitant trauma as well as many other comorbidities of injury [3-5]. 
Burn injuries are also known to lead to significant immune dysregulation that is commonly 
thought to contribute to the difficulties patients experience in overcoming their injury [6-8]. One 
significant comorbidity frequently found among burn patients is presence of inhalation injury, 
which is commonly associated with an increase in hospital length of stay, bacterial infections and 
mortality [9-15].  
Treatment of patients with a burn injury has significantly advanced over recent years, 
however inhalation injury has proven difficult to treat and remains associated with increased 
mortality and morbidity [16, 17]. Inhalation injury and burn injury have independently been 
shown to mediate significant immune dysregulation [18-24]. Studies of patient populations 
indicate that each injury independently causes immune dysregulation, and that their combined 
effects result in damage in excess of that expected due to individual contributions from each 
injury [25]. Although combined injury is known to cause significant complications and lead to 
worsened outcome, few models have been generated that examine the immune-mediated effects 
of combined burn and inhalation injury [26, 27].  
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Studies have indicated that either burn injury or inhalation injury alone can lead to 
increased neutrophil presence in the pulmonary compartment [27-31]. Neutrophils present in the 
pulmonary vasculature and alveolar spaces often lead to production of reactive oxygen and 
nitrogen species, resulting in subsequent damage to the pulmonary compartment [30, 32-34].  
Studies have also indicated that pulmonary damage due to smoke inhalation is associated with 
increased oxidative stress and damage [32, 35], which often occur in the presence of neutrophils. 
Additionally, presence of neutrophils in the bronchial spaces has been associated with immune 
dysfunction and increased susceptibility to bacterial infection [36-38]. Altered production of 
oxidants, as well as alterations in the levels of nitric oxide have been show to contribute to 
pathology after burn injury as well [39, 40]. Some labs have indicated that inhibition of inducible 
nitric oxide synthase (iNOS), a molecule involved in production of nitric oxide, is a potential 
therapeutic with effective treatment potential in ovine animal models [41, 42].  
In this study we utilized a recently developed murine model of combined burn and 
inhalation injury to examine alterations in early and late immune responses after injury. We 
hypothesized that a combined inhalation and burn injury would lead to immunosuppression 
similar to that seen in human populations. We additionally examined the therapeutic potential of 
antioxidant-focused therapies in treatment of animals in our model to improve outcome after 




Eight to twelve-week-old female C57BL/6 mice weighing between 18-21g were 
purchased from Taconic Farms for use in this study. Additional mice deficient in gp91phox 
machinery or NOS2 were utilized for a subset of experiments. Mice were anesthetized using 
tribromoethanol (475mg/kg body weight, Sigma-Aldrich) and then shaved dorsally and given a 
subcutaneous injection of morphine (3mg/kg body weight, West-Ward Pharmaceuticals). A 
subset of mice were administered a 20% total body surface area burn injury as previously 
described [43-45]. A 65-gram copper rod (1.9cm in diameter) was heated to 100°C in a hot water 
bath and then held to the dorsum/flank of the animal for four separate applications lasting 10 
seconds each to achieve a full-thickness contact burn. Inhalation injury was then applied to a 
subset of mice as previously described in chapter 3. Briefly, following burn or sham procedure 
all mice were then placed on an intubation platform (Penn Century) and their trachea were 
visualized using a laryngoscope. A catheter (22Gx1”, Exel) was then placed between the vocal 
chords and mice were secured to a platform and placed in an animal induction platform 
(Stoelting NC9296517). A side-arm flask was placed on a hot plate in a dedicated fume hood and 
set to 500°C. Approximately 50g sectioned plywood (2.5cm x 8cm, Lowe’s Item #12206 Model 
# 776391100000) was heated to induce smoldering and generate smoke. Air was then pumped 
into the flask at constant pressure, resulting in flow of smoke into the induction chamber. Smoke 
density in the chamber was visually assessed and considered appropriate when visual obstruction 
was obtained at a depth of 1-1.5inches from chamber wall. If thinning of smoke was necessary 
the chamber door was vented to maintain a consistent thickness of smoke. Each animal was 
exposed to the smoke three times for exposures lasting two minutes each, followed by one 
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minute of air exposure (fully venting the chamber). Animals were allowed to recover on a heated 
surface until anesthesia subsided and then were given an intraperitoneal injection with lactated 
Ringer’s solution (0.1 mL/g body weight: Hospira, Lake Forest, IL). Mice were then placed in 
individual cages and given food and water ad libitum and monitored twice daily. All Sham 
animals underwent all interventions with the exceptions of application of the cooper rod and 
while in the induction chamber were exposed to air only rather than smoke particles.  
All animals were housed in the UNC Chapel Hill Department of Comparative Medicine’s 
specific pathogen-free animal housing facilities and all protocols and procedures were approved 
by the University of North Carolina’s Institutional Animal Care and Use Committee in 
accordance with NIH-specified guidelines.  
BAL and Whole lung tissue isolation 
Mice were killed through exposure to isoflurane after which Bronchoalveolar lavage was 
conducted to collect cells from the airway as previously described [46-48]. Dissection was 
performed to expose the trachea and a catheter (22G x 1”, Exel) was inserted into the trachea and 
tied off with a thread. A syringe containing 1mL PBS with 0.6mM EDTA was attached to the 
end of the cather, and 0.6mL of solution was washed into the lungs, after which the lungs were 
massaged. The same syringe was used for two more washes which were then collected into a 
tube for primary BAL washes. A second and third syringe were then used to repeat the collection 
procedure, resulting in nine washes with 3 mL solution used for each mouse.  Samples were then 
centrifuged (5 min, 12,000 RCF) and supernatants were collected and stored (-20°C) for further 
analysis at a later date. Cells pelleted were then used for further analysis. Identification of protein 
content of BAL supernatant was determined using a Bradford colorimetric protein assay 
according to manufacturer’s instructions (Bio-Rad, #5000006). Addtionally, BAL supernatant 
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was utilized to characterize cytokines present in the airways. Samples were processed for 
analysis on a Bio-plex mouse chemokine panel 33-plex (Bio-Rad #12002231) according to 
manufacturers protocol. Samples were washed using the Bio-Plex Pro wash station (Bio-Rad 
#30034376) and analyzed using the Bio-Plex MAGPIX Multiplex reader (Bio-Rad #171015001). 
 
Lung tissue was also removed from animals and physically separated using sterile razor 
blades. Lung tissue was then placed in 4mL PBS+10% Fetal Bovine Serum (PBS+FBS) 
supplemented with 0.1µg/mouse DNase and 1500 u/mouse collagenase. Samples were then 
shaken at 250rpm at 37°C for 1h to digest tissue and obtain a single cell suspension as previously 
described (insert Julia references if applicable here) [43]. Digested lung sample was then filtered 
with a 100µm cell strainer and then pelleted (5min, 300g). Red blood cells present in the pellet 
were then lysed using ACK lysis (2 minute exposure) after which samples were washed and 
suspended in PBS+FBS for further analysis and use. Cells obtained from BAL washes and whole 
lung tissue processing were then counted using a hemocytometer with 0.01% trypan blue 
viability dye.  
Flow Cytometry 
Fc receptors on cells were blocked using anti-mouse CD16/32 (eBiosciences) as 
previously described [43, 44]. Antibodies against CD45, CD11c, CD11b, Ly6G, F4/80 and/or 
NOS2 were then utilized to stain cells. Cells were then washed twice and then fixed with 1% 
paraformaldehyde. Stained samples were examined on a Dako CyAn (Beckmann-Coulter) and 
data obtained was analyzed using Summit software (Beckman-Coulter). Cells identified as 
CD45+ were than examined to identify neutrophils (CD45+CD11b+CD11c-Ly6G+) and 




All data were examined in GraphPad Prism Version 5.0 for Windows and analyzed using 
a Student’s t-Test or One-Way Analysis of Variance (ANOVA) with a Tukey post-test. Data are 
displayed as mean+/- standard error of the mean (SEM). Statistical significance is indicated as * 
p < 0.05, ** p < 0.005, *** p < 0.001.   
 
Results  
Combined burn and inhalation injury result in significantly increased mortality that is absent in 
the presence of either injury alone. 
 Mice underwent either sham, burn, inhalation, or combined (burn and inhalation) injury 
in an apparatus as previously described in chapter 3. Single injury resulted in nominal mortality, 
however combined injury resulted in approximately a 40% mortality within two weeks of injury 
(Figure 4.1A). Inhalation injury is known to significantly alter lung physiology, therefore we 
assessed levels of protein present in BAL collected from animals at early (96 hour, Figure 4.1B) 
and late (14 days, Figure 4.1C) timepoints after injury. We found that independent of the 
presence of a concomitant burn injury, inhalation injury resulted in increased protein 
concentration within the airways. In order to determine if changes in protein concentration were 
associated with alterations in the cellular composition of the lungs we examined the total number 
of cells present in both the BAL washes and in single cell suspensions obtained from the whole 
lung tissue. We found that there was an inhalation-dependent increase in total cells present in the 
BAL (Figure 4.1D), and a burn-dependent increase in total cells collected from the whole lung 
66 
tissue (Figure 4.1E), a phenotype that persisted until 14 days after injury (Data shown is 
representative of 14 days after injury. 
Burn and inhalation injury result in alterations in the innate immune composition present in the 
lungs. 
 We then utilized flow cytometric analysis to determine if alterations in numbers of cells 
were related to alterations in immune cells compositions. We found that there was an inhalation-
dependent increase in the numbers of neutrophils present in the BALF early after injury (Figure 
4.2A), but no alterations in the number of macrophages (Figure 4.2B). We additionally found 
that this phenotype was replicated at the late timepoint, in spite of the short-lived nature of 
neutrophils (Figures 4.2C and 4.2D). When we analyzed the cells collected from whole lung 
tissue 14 days after injury we found that there was a bun-dependent increase in the total number 
of neutrophils, a phenotype that was heightened in animals that had additionally experienced an 
inhalation injury (Figure 4.2E). We also found that there was a burn-dependent increase in the 
total number of macrophages in the whole lung tissue (Figure 4.2F). 
 To further characterize the overall immune response taking place in the lungs, BAL 
supernatant was analyzed on a Bio-Rad 33-plex array to identify various cytokines that had been 
secreted into the airways. We found that there were significant inhalation-dependent increases in 
the levels of the following cytokines in the airways: IL-1, IL-6, IL-16, CCL7, CCL17, CCL19, 
CCL22, CCL24 and CXCL10 (Figure 4.3A-I). Many of these cytokines function as chemokines 
that regulate recruitment of both innate and adaptive immune cells to a given area, indicating 
activation of the overall immune response. 
Mice who experienced an inhalation injury had increases in both total neutrophils and a 
corresponding increase in total protein in the BAL. We postulated that cells present in the BAL 
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may be leading to increased production of oxidants such as nitric oxide. Using flow cytometry 
we found that there was an increase in intracellular nitric oxide synthase 2 (NOS2) in 
macrophages from inhalation-treated animals, but not in neutrophils (Figure 4.4A and 4.4B). 
Inhibition of production of oxidants results in decreased pulmonary damage and decreased 
neutrophil recruitment after inhalation injury. 
NOS is involved in the intracellular processes involved in utilizing L-Arginine to produce 
L-Citrulline and nitric oxide. Nitric oxide is then utilized by the cell and can cause damage to its 
surrounding environment. In order to decrease pulmonary damage and regulate the immune 
response we administered an inhibitor of nitric oxide production called L-Nitroarginine methyl 
ester (L-NAME) intranasally immediately after inhalation injury. We found that administration 
of L-NAME after inhalation injury resulted in decreased protein concentration in the BAL 
(Figure 4.4C) as well as a decreased total number of neutrophils collected from the BAL (Figure 
4.4D). 
Discussion 
Many labs utilize murine models to identify cellular mechanism and potential therapeutic 
targets for the treatment of burn-associated immune dysfunction [43, 44, 49-51]. In this 
manuscript we utilize a model that has been previously developed in our lab (insert Julia 
reference here) to examine the combined effects of burn and inhalation injury. Our model 
successfully demonstrates immune dysregulation found in patients who are admitted to the 
hospital due to inhalation injury, as is characterized by increased mortality, numbers of 
neutrophils present in the airway and protein present in the airway [52, 53]. Our murine model 
allows us to uniquely examine alterations in the lung tissue, as this is an organ that cannot be 
utilized for study in humans.  
68 
Multiple studies have indicated that after burn and inhalation injury there is an increase in 
neutrophils present in the airway, and that these neutrophils are associated with an increase in 
oxidants and associated oxidative damage of the pulmonary tissues [32, 35, 54-58]. Additionally, 
preliminary studies have been conducted that indicate that after burn injury inhibition of 
production of reactive oxygen species can lead to decreased damage to the lungs, or increased 
clearance of subsequent bacterial infections [56]. Additional studies have demonstrated that 
inhibition of nitric oxide production after inhalation injury resulted in decreased systemic 
indicators of oxidative injury [30]. Our study examined alterations in the lung that took place 
after a combined burn and inhalation injury, and then identified a nitric oxide inhibitor as a 
potential therapeutic to downregulate the immune response after inhalation injury in order to 
prevent excessive immune-mediated damage to the pulmonary system. 
Additionally, our studies found that multiple cytokines are secreted into the airway after 
injury, including immunomodulatory cytokines such as IL-1, IL-6, and IL-16. These cytokines 
are commonly associated with the events of shock and have been found to be elevated in patients 
who are being treated for burn injury [8, 16]. Additionally, studies have indicated that levels of 
IL-1 and IL-6 correlate with poor clinical outcomes among patients [59]. Each of the other 
cytokines and chemokines that were elevated in the BAL are involved in the recruitment of T 
cells, monocytes, macrophages, dendritic cells and neutrophils. Recruitment of these cells would 
lead to increased cell numbers, and overall immune activation to take place at the site of injury, 
potentially leading to worsened damage of the lungs. 
Previous data in our lab has demonstrated that inhalation injury of mice deficient in 
NOS2 do not experience the inhalation-dependent increase in numbers of neutrophils or in 
protein concentration present in the BALF of wildtype mice. This led us to believe that NOS 
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could be a viable target for therapeutic intervention to decrease inhalation-dependent pulmonary 
damage. Clinical trials with non-selective NOS inhibitors in the treatment of shock resulted in 
increased mortality among patients [60]. Indeed, preliminary studies in our lab additionally 
indicated that NOS2 deficiency results in increased mortality late after inhalation injury (Figure 
4.5A). This phenomenon appears to be location-dependent within the body as well, as recent 
studies have demonstrated that intravenous administration of a nitric oxide agonist can improve 
vascularization and response after burn injury [61]. This data combined indicates that specific 
responses need to be targeted, where full ablation of NOS activity results in increased mortality, 
but that moderate inhibition of NOS signaling can prevent damage that takes place after 
inhalation injury. Among patients, ideal treatment strategies would prevent overactivation of the 
immune response that often takes place when patients experience a major shock such as a burn 
injury. However, while it is important to prevent hyperimmunity, it is also essential to maintain 
the integrity of the immune system in order to allow the patient to fight potential pathogens they 
may encounter in order to maintain ideal health. This is why it is essential to identify 
therapeutics that would allow for slight immunomodulation rather than complete polarization of 







Figure 4.1: Combined injury results in increased mortality over time, while major markers 
of pulmonary damage are elevated in an inhalation-dependent manner. Mice underwent 
sham, burn, inhalation or combined injury A) Mice were examined over the course of 14 days 
and mortality was recorded; B) Protein levels detected in BAL primary washes 96hrs after 
injury.; C) Protein levels detected in BAL primary washes 14days after injury.; D) Total number 
of cells that were isolated from the BAL primary and secondary washes 14 days after injury.; E) 
Total number of cells obtained from single cell isolation of lung tissue 14 days after injury. Data 
shown are +/-SEM.  *p<0.05, **p<0.01, and representative of three repeated experiments.  
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Figure 4.2: Innate immune cells are recruited to the airspace and to the pulmonary tissue 
in an injury-dependent manner. Mice underwent sham, burn, inhalation or combined injury, 
and cells isolated were examined via flow cytometric analysis A) Neutrophil numbers collected 
from BAL were found to be increased in an inhalation-dependent manner 96hrs after injury; B) 
No detectable changes in the total number of macrophages collected from BAL were detected 
96hrs after injury.; C) Neutrophil numbers collected from BAL increased in an inhalation-
dependent manner 14days after injury; D) No detectable changes in the total number of 
macrophages in BAL were detected 14days after injury.; E) Total neutrophils obtained from 
single cell isolation of lung tissue 14 days after injury were increased in a burn and combined 
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injury-dependent manner.; F) Total macrophages obtained from single cell isolation of lung 
tissue 14 days after injury were increased in a burn-dependent manner. Data shown are +/-SEM.  
*p<0.05, **p<0.01, and representative of three repeated experiments.  
 
 
Figure 4.3: Multiple cytokines and chemokines are elevated in an inhalation-dependent 
manner 96hrs after inhalation injury. Mice underwent sham, burn, inhalation or combined 
injury, and supernatant collected from BAL washes was analyzed using a Bio-plex mouse 
chemokine panel 33-plex. Inhalation dependent increases in amount of A) IL-1, B) IL-6, C) IL-
16, D) CCL7, E) CCL17, F) CCL19, G) CCL22, H) CCL24, I) CXCL10 were detected. Data 
shown are +/-SEM.  *p<0.05, **p<0.01, and representative of three repeated experiments.  
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Figure 4.4: Nitric oxide generation is involved in pathology of inhalation injury. Mice 
underwent sham, burn, inhalation or combined injury, and cells isolated were examined via flow 
cytometric analysis A) Macrophages present in BAL were found to have an inhalation-depndent 
increase in NOS2 levels as detected by intracellular staining. B) Inhalation injury did not result 
in alterations in NOS2 levels in neutrophils in BAL. C) Intranasal administration of L-NAME at 
the time of injury resulted in slight decrease in protein concentration collected in the BAL after 
inhalation injury. D) Intranasal administration of L-NAME at the time of inhalation injury 
resulted in decreased numbers of neutrophils collected from BAL. Data shown are +/-SEM.  
*p<0.05, **p<0.01, and representative of three repeated experiments.  
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Figure 4.5: Complete ablation of nitric oxide machinery results in increased mortality after 
inhalation injury. Mice underwent sham or inhalation injury, and were monitored over time A) 
Mice deficient in nitric oxide and Reactive oxygen and nitrogen machinery experienced 
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CHAPTER 5: DISCUSSION 
Concluding remarks 
Improvement in the treatment of traumatic burn injury is necessary, however currently 
there are many barriers to burn-associated drug discovery. In order to find and test therapeutics, 
there needs to be a significant improvement in animal models of burn injury that are utilized. 
Any models utilized need to recapitulate the various major markers of disease that are indicated 
among the human patient population. Burn injury causes significant immune dysregulation 
among patients, which leads to increased susceptibility to infection as well as additional injury-
associated complications [1, 2]. Testing of treatments of burn injury will need to address the 
immune dysfunction that takes place, and to improve overall immune responses.  
Many models of burn injury are unable to fully replicate the immune-mediated damage 
that can arise throughout the course of initial injury followed by treatment and recovery.  In 
order for a model to successfully capture the complex nature of burn injury it should exhibit 
similar etiology and molecular mechanisms to those seen among humans. Largely, models 
should be able to successfully detect alterations in levels of cytokines, chemokines, damage-
associated molecular patterns and immune cells present in various tissues that are compromised 
in the human population [3-7].  
In an effort to create effective models of burn injury, our laboratory has recently focused 
on examination of burn models that take into account multiple burn-associated comorbidities, 
such as concomitant infection and/or radiation exposure [8-10]. Our studies indicated similar 
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findings to those of other groups, namely that early immune dysfunction after injury is relatively 
easy to recapitulate [9, 11], however, late after injury burn-treated animals often experience 
heightened immune responses that are protective against bacterial challenge, a phenotype that 
does not reflect what takes place among human counterparts [12, 13]. We have additionally 
found that this phenotype is overcome if burn is administered in the presence of an additional 
burn-associated comorbidity, such as a radiation injury [8, 10].  
Models generated 
In this dissertation we examine two novel models of burn-associated comorbidities and 
their respective effects on the immune system. We noted that previous literature indicates that 
following burn injury, a single incidence of infection does not lead to increased mortality [14]. 
However, repeated bacterial exposures led to approximately a 36% increase in mortality. Skin 
represents a significant barrier that protects individuals from the outside environment, and a burn 
wound represents a significant disruption to that barrier that could potentially allow patients to be 
exposed to additional bacteria from their environment. It is reasonable to believe that patients 
would experience multiple bacterial exposures during the course of their treatment of a burn 
injury. Therefore, we generated the model discussed in chapter 2 of this thesis, in which animals 
were infected with Pseudomonas aeruginosa twice in order to elicit immune responses that may 
reflect those seen among burn patients.  
In chapters 3 and 4 of this thesis we focus on the development of a model of inhalation 
injury. One significant byproduct of burning compounds is smoke generated. Many patients who 
experience a flame burn arrive at the hospital with an associated inhalation injury, resulting in 
approximately 10-20% of all burn patients treated at hospitals having an inhalation injury [15]. 
82 
Presence of a burn-associated inhalation injury leads to increased mortality, complicated 
treatment, and lengthened hospital stays for patients [16-18]. Many animal models have sought 
to uncover the underlying mechanism of inhalation-dependent alterations of the immune system 
[19-21], however few groups have examined the combinatory effects of burn and inhalation 
injury [22] in spite of the fact that studies indicate that damage after burn and inhalation injury 
combined is more significant than is attributable to each injury alone [22]. We created a model 
that utilizes particle board, a compound commonly found in building materials, to create a 
clinically-relevant model of study of inhalation injury that we have utilized to examine the 
effects of inhalation injury independently as well as associated with a burn injury.  
Commonalities between models of burn injury. 
One commonality between studies of patients and burn-associated models is that there is 
alteration in the immune profile after burn injury. Largely, immediately after burn injury the 
wound causes significant damage to the immune compartment that is characterized by the 
generation of damage-associated molecular patterns (DAMPS) [1, 3, 4]. DAMPS generated lead 
to alterations in the cytokine profile and immune cell phenotypes found systemically. Among 
burn patients, a leading cause of mortality is burn-associated pulmonary damage and associated 
infections and pneumonia [23]. Due to the importance of the pulmonary system to survival and 
the relative susceptibility of burn patients to pulmonary complications, we chose to focus our 
research on the pulmonary compartment in examination of both our models of burn-associated 
comorbidities.  
We found that in both models, burn injury caused the recruitment of neutrophils to the 
pulmonary tissue. These neutrophils were not present in the airway of the lungs unless there was 
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some additional stimulus to promote the recruitment of neutrophils to the airspace. For example, 
infection of animals with an airway infection resulted in increased numbers of neutrophils to be 
present in the airspace. Additionally, in our model of inhalation injury we found that the 
presence of an inhalation injury resulted in neutrophil recruitment to the airspace, however, this 
phenotype occurred independently of the burn injury. We have additionally shown that 
recruitment of these cells corresponds with damage to the area, potentially creating an 
environment in which bacteria could thrive (depicted in figure 5.1). 
 
Figure 5.1: Comparison of a healthy and burn+comorbidity environment. After burn injury, 
various DAMPS will be released, however it is only when there is an additional stimulus in the 
airways that cells are recruited into the airspace, potentially contributing to increased bacterial 
burden and worsened outcomes after experiencing a burn+comorbidity. 
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We also found that neutrophil intracellular levels of reactive oxygen and nitrogen species 
(RONS) were significantly altered after burn injury. Burn injury resulted in increased levels of 
RONS. We also found that inhalation injury resulted in alterations of levels of nitric oxide 
synthase. This corresponds with previous data that has been published indicating that regulation 
of oxidative stress after burn injury is significantly altered and represents a potential target for 
improved healing [24, 25]. We additionally found that it is possible to alter levels of RONS, and 
that targeting nitric oxide could prove a successful potential therapeutic for treatment after 
inhalation injury. 
Additionally, we found that burn injury and its associated comorbidities lead to 
alterations in the production of immune-mediated cytokines and chemokines. Indeed, injury-
associated cytokine production led to production of chemokines that are commonly associated 
with communication and regulation between the adaptive and innate immune systems. 
Alterations in levels of cytokines such as IL-6, IL-10 and IL-12 indicate that wound-induced 
damage in our models is able to generate significant alterations in the immune compartment that 
are similar to changes seen in the human population. After inhalation injury we also found 
increased levels of a number of chemokines associated with recruitment of dendritic cells, B 
cells and T cells. It would be important for future studies to focus on examining how these 
additional cell types are altered by these injuries and characterize how to further improve the 
immune response after injury. 
Conclusion 
Comorbidities of burn injury are known to result in significant increases in mortality. The 
models that have been generated during the course of this thesis have allowed for improved 
85 
probing of the immune responses. These models also represent a powerful tool that can be 
utilized to answer many clinical questions and address variables that significantly affect burn 
injury. For example, studies have indicated that severity of inhalation injury is dependent on the 
source utilized to generate smoke particles. Using our model, we could study various sources of 
smoke to examine both universal and source-dependent differences in immune consequences of 
inhalation injury. Additionally, these models could be used to examine multiple pre-clinical 
treatments in order to discover therapies that could significantly improve outcome after burn 
injury and promote recovery. Finally, we could also study the effects of additional comorbidities 
that are involved in driving responses after burn injury, such as age, BMI, smoker status, and 
presence of alcohol in the system at the time of burn injury in order to further replicate factors 
that affect clinical outcomes. These studies are necessary and essential in order to improve 
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